Suven Life Sciences has won four product patents for its new chemical entities designed for treatment of neurodegenerative diseases. These were granted in Europe, Sri Lanka and South Korea for compounds that are being developed as therapeutic agents for Alzheimer's disease, Parkinson's and Schizophrenia, among others.
The cognitive disorders for which these drugs would be developed were a $ 30-billion market globally. With this, the biopharma company has a total of 11 granted patents from Europe, eight from Sri Lanka and five from South Korea. These patents are its exclusive intellectual property, achieved through internal research. Products developed out of these inventions may be outlicensed at different phases of clinical development.crackcrack
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: